Publications (original articles or review articles) published in 2023 from OUS - Department of Infectious Diseases
12 publications found
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis
J Neurol, 1-14 (in press)
DOI 10.1007/s00415-023-11768-1, PubMed 37184659
Mortality and Sequential Organ Failure Assessment Score in Patients With Suspected Sepsis: The Impact of Acute and Preexisting Organ Failures and Infection Likelihood
Crit Care Explor, 5 (2), e0865
DOI 10.1097/CCE.0000000000000865, PubMed 36844375
The Role of Procalcitonin as an Antimicrobial Stewardship Tool in Patients Hospitalized with Seasonal Influenza
Antibiotics (Basel), 12 (3)
DOI 10.3390/antibiotics12030573, PubMed 36978440
Differential response to prolonged amoxicillin treatment: long-term resilience of the microbiome versus long-lasting perturbations in the gut resistome
Gut Microbes, 15 (1), 2157200
DOI 10.1080/19490976.2022.2157200, PubMed 36576106
A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation
Hepatology, 77 (3), 715-728
DOI 10.1002/hep.32773, PubMed 36056902
TiSA: TimeSeriesAnalysis-a pipeline for the analysis of longitudinal transcriptomics data
NAR Genom Bioinform, 5 (1), lqad020
DOI 10.1093/nargab/lqad020, PubMed 36879899
Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection
NEJM Evid, 2 (3)
DOI 10.1056/evidoa2200302, PubMed 37213438
Host blood-based biosignatures for subclinical TB and incipient TB: A prospective study of adult TB household contacts in Southern India
Front Immunol, 13, 1051963
DOI 10.3389/fimmu.2022.1051963, PubMed 36713386
[Not Available]
Tidsskr Nor Laegeforen, 143 (7)
DOI 10.4045/tidsskr.23.0301, PubMed 37158510
Visual diagnosis of female genital schistosomiasis in Zambian women from hand-held colposcopy: agreement of expert image review and association with clinical symptoms
Wellcome Open Res, 8, 14
DOI 10.12688/wellcomeopenres.18737.2, PubMed 36864924
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
Crit Care, 27 (1), 9
DOI 10.1186/s13054-022-04205-8, PubMed 36627655
Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19
Crit Care, 27 (1), 69
DOI 10.1186/s13054-023-04356-2, PubMed 36814280